newsfilter
← Latest News
GlobeNewswire·

Affimed Announces Listing Transfer to Nasdaq Capital Markets

MANNHEIM, Germany, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD) ("Affimed", or the "Company"), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight